Clinical Trial Update: Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined phase 1/2 trial evaluating cisplatin or carboplatin with etoposide with or without sunitinib malate in extensive-stage small cell lung cancer has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Sunitinib malate (sunitinib malate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-14